Use of Immune Checkpoint Inhibitors in Refractory Mycosis Fungoides and Sézary Syndrome: A Systematic Review

被引：0
|
作者：
Rijal, Hibo [1 ]
Moustaqim-Barrette, Amina [2 ]
Martinez Villarreal, Amelia [3 ]
Litvinov, Ivan V. [3 ,4 ]
机构：
[1] Queens Univ, Sch Med, Kingston, ON, Canada
[2] McGill Univ, Fac Med, Montreal, PQ, Canada
[3] McGill Univ Hlth Ctr, Div Dermatol, 1001 Decarie Vlvd,Rm E02-6236, Montreal, PQ H4A 3J1, Canada
[4] McGill Univ, Div Dermatol, Montreal, PQ, Canada
来源：
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY | 2025年 / 29卷 / 02期
关键词：
cutaneous T-cell lymphomas; mycosis fungoides; S & eacute; zary syndrome; immune checkpoint inhibitor; treatment; therapeutic; systematic review;
D O I：
10.1177/12034754241290816
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：179 / 180
页数：2
相关论文
共 50 条
  • [41] A systematic review of the cost and cost-effectiveness studies of immune checkpoint inhibitors
    Verma, Vivek
    Sprave, Tanja
    Haque, Waqar
    Simone, Charles B., II
    Chang, Joe Y.
    Welsh, James W.
    Thomas, Charles R., Jr.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2018, 6
  • [42] Systematic Review of the Safety of Immune Checkpoint Inhibitors Among Kidney Transplant Patients
    Manohar, Sandhya
    Thongprayoon, Charat
    Cheungpasitporn, Wisit
    Markovic, Svetomir N.
    Herrmann, Sandra M.
    KIDNEY INTERNATIONAL REPORTS, 2020, 5 (02): : 149 - 158
  • [43] The Current Status of Immune Checkpoint Inhibitors in Neuro-Oncology: A Systematic Review
    Brahm, Cyrillo G.
    van Linde, Myra E.
    Enting, Roelien H.
    Schuur, Maaike
    Otten, Rene H. J.
    Heymans, Martijn W.
    Verheul, Henk M. W.
    Walenkamp, Annemiek M. E.
    CANCERS, 2020, 12 (03)
  • [44] Interferon and low dose methotrexate improve outcome in refractory mycosis fungoides/Sezary syndrome
    Aviles, Agustin
    Nambo, Jesus
    Neri, Natividad
    Castaneda, Claudia
    Cleto, Sergio
    Gonzalez, Martha
    Huerta-Guzman, Judith
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2007, 22 (06) : 836 - 840
  • [45] Quality of life in patients with mycosis fungoides and Sezary syndrome: a review of the literature
    Ottevanger, Rosanne
    van Beugen, Sylvia
    Evers, Andrea
    Willemze, Rein
    Vermeer, Maarten
    Quint, Koen
    EUROPEAN JOURNAL OF CANCER, 2021, 156 : S65 - S65
  • [46] Mycosis fungoides and Sezary syndrome: clinical, histopathological and immunohistochemical review and update
    Yamashita, Thamy
    Fernandes Abbade, Luciana Patricia
    Alencar Marques, Mariangela Esther
    Marques, Silvio Alencar
    ANAIS BRASILEIROS DE DERMATOLOGIA, 2012, 87 (06) : 817 - 830
  • [47] Efficacy of immune checkpoint inhibitors for NSCLC in patients with different age: A systematic review and meta-analysis
    Zhang, Qi
    Liang, Xiao-yan
    Wang, Ze-sheng
    Sun, An
    Cao, Tin-bao
    Zhang, Yu-Peng
    Li, Nan
    Yi, Tong-ying
    Qu, Kun-Peng
    ASIAN JOURNAL OF SURGERY, 2024, 47 (11) : 4691 - 4698
  • [48] Severe Cutaneous Adverse Reactions Associated with Immune Checkpoint Inhibitors: A Systematic Review of Clinical Characteristics and Management
    Sood, Siddhartha
    Bagit, Ahmed
    Waked, Jihad Abou Ali
    Perlmutter, Jonah
    Tarafdar, Nawar
    Maliyar, Khalad
    Sachdeva, Muskaan
    Abduelmula, Abrahim
    Mufti, Asfandyar
    Yeung, Jensen
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2025,
  • [49] Alemtuzumab is an effective third-line treatment versus single-agent gemcitabine or pralatrexate for refractory Sézary syndrome: a systematic review
    Jacob R. Stewart
    Neil Desai
    Syed Rizvi
    Hong Zhu
    Heather W. Goff
    European Journal of Dermatology, 2018, 28 : 764 - 774
  • [50] Successful use of allogeneic stem cell transplantation for treatment-refractory mycosis fungoides
    Hoff, N. P.
    Groffik, A.
    Mota, R.
    Pippirs, U.
    Hengge, U. R.
    Kobbe, G.
    Homey, B.
    Bruch-Gerharz, D.
    HAUTARZT, 2008, 59 (10): : 779 - 782
12345